CB 2 cannabinoid receptor agonists attenuate TNF-α-induced human vascular smooth muscle cell proliferation and migration

M. Rajesh, P. Mukhopadhyay, G. Haskó, J. W. Huffman, K. Mackie, P. Pacher

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Background and purpose: Vascular smooth muscle proliferation and migration triggered by inflammatory stimuli are involved in the development and progression of atherosclerosis and restenosis. Cannabinoids may modulate cell proliferation in various cell types through cannabinoid 2 (CB 2) receptors. Here, we investigated the effects of CB 2 receptor agonists on TNF-α-induced proliferation, migration and signal transduction in human coronary artery smooth muscle cells (HCASMCs). Experimental approach: HCASMCs were stimulated with TNF-α. Smooth muscle proliferation was determined by the extent of BrdU incorporation and the migration was assayed by modified Boyden chamber. CB 2 and/or CB 1 receptor expressions were determined by immunofluorescence staining, western blotting, RT-PCR, real-time PCR and flow cytometry. Key results: Low levels of CB 2 and CB 1 receptors were detectable in HCASMCs compared to the high levels of CB 2 receptors expressed in THP-1 monocytes. TNF-α triggered up to ∼80% increase (depending on the method used) in CB 2 receptor mRNA and/or protein expression in HCASMCs, and induced Ras, p38 MAPK, ERK 1/2, SAPK/JNK and Akt activation, while increasing proliferation and migration. The CB 2 agonists, JWH-133 and HU-308, dose-dependently attenuated these effects of TNF-α. Conclusions and implications: Since the above-mentioned TNF-α-induced phenotypic changes are critical in the initiation and progression of atherosclerosis and restenosis, our findings suggest that CB 2 agonists may offer a novel approach in the treatment of these pathologies by decreasing vascular smooth muscle proliferation and migration.

Original languageEnglish
Pages (from-to)347-357
Number of pages11
JournalBritish Journal of Pharmacology
Volume153
Issue number2
DOIs
Publication statusPublished - Jan 2008

Fingerprint

Cannabinoid Receptor Agonists
Cannabinoids
Vascular Smooth Muscle
Cannabinoid Receptors
Smooth Muscle Myocytes
Cell Movement
Coronary Vessels
Cell Proliferation
Atherosclerosis
p38 Mitogen-Activated Protein Kinases
Bromodeoxyuridine
Fluorescent Antibody Technique
Smooth Muscle
Real-Time Polymerase Chain Reaction
Monocytes
Signal Transduction
Flow Cytometry
Western Blotting
Pathology
Staining and Labeling

Keywords

  • Antibodies
  • Cannabinoid 2 receptor
  • Cannabinoids
  • Migration
  • Proliferation
  • Smooth muscle

ASJC Scopus subject areas

  • Pharmacology

Cite this

CB 2 cannabinoid receptor agonists attenuate TNF-α-induced human vascular smooth muscle cell proliferation and migration. / Rajesh, M.; Mukhopadhyay, P.; Haskó, G.; Huffman, J. W.; Mackie, K.; Pacher, P.

In: British Journal of Pharmacology, Vol. 153, No. 2, 01.2008, p. 347-357.

Research output: Contribution to journalArticle

Rajesh, M. ; Mukhopadhyay, P. ; Haskó, G. ; Huffman, J. W. ; Mackie, K. ; Pacher, P. / CB 2 cannabinoid receptor agonists attenuate TNF-α-induced human vascular smooth muscle cell proliferation and migration. In: British Journal of Pharmacology. 2008 ; Vol. 153, No. 2. pp. 347-357.
@article{f862ba7ba3484d569111977a2f307378,
title = "CB 2 cannabinoid receptor agonists attenuate TNF-α-induced human vascular smooth muscle cell proliferation and migration",
abstract = "Background and purpose: Vascular smooth muscle proliferation and migration triggered by inflammatory stimuli are involved in the development and progression of atherosclerosis and restenosis. Cannabinoids may modulate cell proliferation in various cell types through cannabinoid 2 (CB 2) receptors. Here, we investigated the effects of CB 2 receptor agonists on TNF-α-induced proliferation, migration and signal transduction in human coronary artery smooth muscle cells (HCASMCs). Experimental approach: HCASMCs were stimulated with TNF-α. Smooth muscle proliferation was determined by the extent of BrdU incorporation and the migration was assayed by modified Boyden chamber. CB 2 and/or CB 1 receptor expressions were determined by immunofluorescence staining, western blotting, RT-PCR, real-time PCR and flow cytometry. Key results: Low levels of CB 2 and CB 1 receptors were detectable in HCASMCs compared to the high levels of CB 2 receptors expressed in THP-1 monocytes. TNF-α triggered up to ∼80{\%} increase (depending on the method used) in CB 2 receptor mRNA and/or protein expression in HCASMCs, and induced Ras, p38 MAPK, ERK 1/2, SAPK/JNK and Akt activation, while increasing proliferation and migration. The CB 2 agonists, JWH-133 and HU-308, dose-dependently attenuated these effects of TNF-α. Conclusions and implications: Since the above-mentioned TNF-α-induced phenotypic changes are critical in the initiation and progression of atherosclerosis and restenosis, our findings suggest that CB 2 agonists may offer a novel approach in the treatment of these pathologies by decreasing vascular smooth muscle proliferation and migration.",
keywords = "Antibodies, Cannabinoid 2 receptor, Cannabinoids, Migration, Proliferation, Smooth muscle",
author = "M. Rajesh and P. Mukhopadhyay and G. Hask{\'o} and Huffman, {J. W.} and K. Mackie and P. Pacher",
year = "2008",
month = "1",
doi = "10.1038/sj.bjp.0707569",
language = "English",
volume = "153",
pages = "347--357",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - CB 2 cannabinoid receptor agonists attenuate TNF-α-induced human vascular smooth muscle cell proliferation and migration

AU - Rajesh, M.

AU - Mukhopadhyay, P.

AU - Haskó, G.

AU - Huffman, J. W.

AU - Mackie, K.

AU - Pacher, P.

PY - 2008/1

Y1 - 2008/1

N2 - Background and purpose: Vascular smooth muscle proliferation and migration triggered by inflammatory stimuli are involved in the development and progression of atherosclerosis and restenosis. Cannabinoids may modulate cell proliferation in various cell types through cannabinoid 2 (CB 2) receptors. Here, we investigated the effects of CB 2 receptor agonists on TNF-α-induced proliferation, migration and signal transduction in human coronary artery smooth muscle cells (HCASMCs). Experimental approach: HCASMCs were stimulated with TNF-α. Smooth muscle proliferation was determined by the extent of BrdU incorporation and the migration was assayed by modified Boyden chamber. CB 2 and/or CB 1 receptor expressions were determined by immunofluorescence staining, western blotting, RT-PCR, real-time PCR and flow cytometry. Key results: Low levels of CB 2 and CB 1 receptors were detectable in HCASMCs compared to the high levels of CB 2 receptors expressed in THP-1 monocytes. TNF-α triggered up to ∼80% increase (depending on the method used) in CB 2 receptor mRNA and/or protein expression in HCASMCs, and induced Ras, p38 MAPK, ERK 1/2, SAPK/JNK and Akt activation, while increasing proliferation and migration. The CB 2 agonists, JWH-133 and HU-308, dose-dependently attenuated these effects of TNF-α. Conclusions and implications: Since the above-mentioned TNF-α-induced phenotypic changes are critical in the initiation and progression of atherosclerosis and restenosis, our findings suggest that CB 2 agonists may offer a novel approach in the treatment of these pathologies by decreasing vascular smooth muscle proliferation and migration.

AB - Background and purpose: Vascular smooth muscle proliferation and migration triggered by inflammatory stimuli are involved in the development and progression of atherosclerosis and restenosis. Cannabinoids may modulate cell proliferation in various cell types through cannabinoid 2 (CB 2) receptors. Here, we investigated the effects of CB 2 receptor agonists on TNF-α-induced proliferation, migration and signal transduction in human coronary artery smooth muscle cells (HCASMCs). Experimental approach: HCASMCs were stimulated with TNF-α. Smooth muscle proliferation was determined by the extent of BrdU incorporation and the migration was assayed by modified Boyden chamber. CB 2 and/or CB 1 receptor expressions were determined by immunofluorescence staining, western blotting, RT-PCR, real-time PCR and flow cytometry. Key results: Low levels of CB 2 and CB 1 receptors were detectable in HCASMCs compared to the high levels of CB 2 receptors expressed in THP-1 monocytes. TNF-α triggered up to ∼80% increase (depending on the method used) in CB 2 receptor mRNA and/or protein expression in HCASMCs, and induced Ras, p38 MAPK, ERK 1/2, SAPK/JNK and Akt activation, while increasing proliferation and migration. The CB 2 agonists, JWH-133 and HU-308, dose-dependently attenuated these effects of TNF-α. Conclusions and implications: Since the above-mentioned TNF-α-induced phenotypic changes are critical in the initiation and progression of atherosclerosis and restenosis, our findings suggest that CB 2 agonists may offer a novel approach in the treatment of these pathologies by decreasing vascular smooth muscle proliferation and migration.

KW - Antibodies

KW - Cannabinoid 2 receptor

KW - Cannabinoids

KW - Migration

KW - Proliferation

KW - Smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=38349113185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38349113185&partnerID=8YFLogxK

U2 - 10.1038/sj.bjp.0707569

DO - 10.1038/sj.bjp.0707569

M3 - Article

C2 - 17994109

AN - SCOPUS:38349113185

VL - 153

SP - 347

EP - 357

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 2

ER -